Pharmafile Logo
Pharmafocus logo
Advanced Search

Latest Feature Articles

kris-sterkens-23052017-hr-1

Working Life: Kris Sterkens, Company Group Chairman, Janssen EMEA

Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing | J&J, JJ, Janssen, Johnson & Johnson, Kris Sterkens, pharma

Pharmafile.com sat down with Kris Sterkens, Company Group Chairman of Janssen’s EMEA operations to discuss nearly three decades at the …

Feature
fighting_cancer

Looking to the future of oncology

Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing | CAR T, CAR-T, Cancer, feature, oncology, pharma

The oncology field moves so quickly that it can be hard to keep track of the latest innovations. Ben Hargreaves …

Feature
cystic_fibrosis_insider_interview

Transforming cystic fibrosis treatment

Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing | Vertex, biotech, cystic fibrosis, drugs, pharma, pharmaceutical

Fred van Goor, Principle Research Fellow at Vertex Pharmaceuticals, discusses his history of work in cystic fibrosis and how the …

Feature

Patient experience: Living with ovarian cancer

Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing | Cancer, Ingrid Copperman, feature, ovarian cancer, patient experience, pharma

Ingrid Copperman recounts the many ways she has dealt with her diagnosis, as well as how the power of social …

Feature
brexit-referendum-uk-1468255193y2p

Brexit Health Alliance: Brexit and the impact on patient access to medicines

Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing | Brexit Health Alliance, brexit, feature, market access, pharma

On behalf of the Brexit Health Alliance, Sarah Collen, Senior Policy Manager at NHS Confederation, details the potential negative fallout …

Feature
eu-flag-2108026_960_720

Six reasons why UK pharma has more to gain, than fear, from Brexit

Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing | EMA, EU, biotech, brexit, drugs, hard Brexit, pharma, pharmaceutical

There are good reasons to think exiting the EU represents a major opportunity for this dynamic and world-leading industry, argues …

Feature

Working Life: Chris Round, Head of EMEA Region, Merck KGaA

Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing | Chris Round, MSD, Merck, Merck KGaA, Working Life, pharma

Merck KGaA’s Chris Round, Head of EMEA Region, spoke with Pharmafile.com to discuss his time at both the US and …

Feature
12_rare

The need for flexible appraisal of rare disease medicines

Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing | Amryt Pharma, feature, pharma, rare disease, rare diseases

Recent data has shown that England is, on average, slower than Germany, France, Spain and Italy in making orphan medicinal …

Feature
shutterstock_79370437

Drug safety: EudraVigilance and an evolving system

Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing | drug safety, pharma, pharmacovigilance

The importance of drug safety is back in the news due to sodium valproate and Ben Hargreaves examines how the …

Feature
shutterstock_141105490

Uncovering trends in the future of real world data

Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing | Amgen, AstraZeneca, feature, pharma, real world data, real world evidence

A new report has canvassed the intentions of industry players in the use of real world data and evidence over …

Feature
david_meek_web

Ipsen: Becoming a “development powerhouse”

Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing | David Meek, Insider Interview, ipsen, pharma

Immediately following the release of impressive full year financials, Ipsen CEO David Meek speaks on how the company is hitting …

Feature
aaa

Insider Interview: Allergan’s R&D Chief on plans to be “the headache company”

Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing | Allergan, David Nicholson, Insider Interview, migraine, pharma

Speaking to Pharmafocus , David Nicholson, Chief R&D Officer at Allergan, revealed that the company has big plans in the …

Feature
img_9530_resized

Patient experience: Living with multiple myeloma

Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing | Cancer, feature, mutiple myeloma, patient experience, pharma

Pharmafocus talks to John Ellwood about the challenges of being diagnosed with multiple myeloma and how having a strong support …

Feature
network-1989146_960_720

Taking a look behind the scenes of Serialisation

Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing | Serialization, biotech, drugs, pharma, pharmaceutical, serialisation

The reaction from the pharmaceutical industry has been mixed since the announcement of serialisation requirements. Ben Hargreaves discovers the challenges …

Feature
online_feature_image

New Year, new goals

Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing | CRUK, Cancer Research UK, Chiesi, EMA, FDA, Genetic Alliance, pharma

With the New Year begun in earnest, Pharmafocus speaks to a range of players in pharma and the life sciences …

Feature
Load more Feature Articles
The Gateway to Local Adoption Series

Latest content

Rhythm AI’s STAR Apollo system receives FDA clearance for atrial fibrillation

February 12, 2026

iOrganBio appoints Karol Jarzabek as Chief Operating Officer

February 12, 2026

Ensera Design expands UK leadership team with new senior appointments

February 11, 2026

Infinitopes announces $15.4m in additional seed funding to advance cancer vaccine

February 11, 2026

Angelini Pharma appoints Roberto Scrivo as Chief of External Affairs, Communication and Sustainability Officer

February 10, 2026